$CRH·8-K

CRH PUBLIC LTD CO · Jul 17, 4:11 PM ET

Compare

CRH PUBLIC LTD CO 8-K

Research Summary

AI-generated summary

Updated

CRH Announces $2.5B Term Loan for Arcosa Merger Financing

What Happened

  • CRH Public Limited Company (CRH) filed an 8-K on July 17, 2026 confirming that CRH, as guarantor, and CRH America Finance, Inc., as borrower, entered a three-year $2.5 billion Term Loan Facility to help fund the previously announced acquisition of Arcosa, Inc. (Merger). This follows the June 22, 2026 Merger Agreement and an initial $5.75 billion Bridge Facility entered at that time.
  • As a result of the Term Loan Facility, the outstanding commitments under the Bridge Facility were reduced from $5.75 billion to $3.25 billion. Borrowings under the Term Loan bear interest at SOFR plus a ratings-based margin and include a quarterly ticking fee that ramps from 0% in the first three months to 30% thereafter. The Term Loan includes customary investment‑grade terms and contains no financial covenants. Availability is subject to the same conditions as the Bridge Facility.

Key Details

  • $2.5 billion three-year Term Loan Facility committed on July 17, 2026.
  • Bridge Facility commitments reduced to $3.25 billion (from $5.75 billion).
  • Interest: SOFR + ratings-based margin; ticking fee: 0% (months 1–3), 10% (month 4), 20% (month 5), 30% (month 6+).
  • No financial covenants; availability subject to Bridge Facility conditions. CRH may replace some or all remaining Bridge commitments with alternative financings before closing.

Why It Matters

  • This financing step demonstrates CRH’s progress toward funding the Arcosa acquisition, reducing immediate bridge exposure while locking in $2.5B of committed term financing.
  • Loan pricing mechanics (SOFR + margin) and ticking fees define near-term borrowing costs; the absence of financial covenants is notable for credit flexibility.
  • Remaining financing is not fully committed and depends on market conditions; closing still requires satisfying merger conditions (including Arcosa shareholder and regulatory approvals), so funding and deal completion are not guaranteed.

Loading document...